1
unit can bind DNA as a monomer in vitro, but its affinity 1 Department of Biochemistry for DNA is 5-to 10-fold greater when it binds DNA as Dartmouth Medical School a CBF␣:␤ heterodimer (Ogawa et al., 1993a; Wang et al., Hanover, New Hampshire 03755 1993) . The only function ascribed to the CBF␤ subunit is 2 Department of Chemistry that it increases the affinity of the CBF␣ subunit for DNA.
Dartmouth College
There is no evidence, for example, to suggest that the Hanover, New Hampshire 03755 CBF␤ subunit contains a transcriptional activation do-3 Howard Hughes Medical Institute main or modulates the intracellular localization of the The Children's Hospital CBF␣ subunit. 300 Longwood Avenue CBF␣ subunits are encoded by three distinct genes Boston, Massachusetts 02215 in mice and humans: CBFA1, CBFA2 (AML1), and CBFA3 4 National Center for Human Genome Research (Miyoshi et al., 1991; Bae et al., 1993 Bae et al., , 1995 Ogawa et National Institutes of Health al., 1993b; Levanon et al., 1994) . The CBFA1 and CBFA2 Bethesda, Maryland 20892-4470 genes are expressed in a restricted set of tissues (Satake 5 Departments of Anatomy and Pathology et al., 1995; Simeone et al., 1995) , while the CBFA3 gene Dartmouth Medical School appears to be expressed ubiquitously (Bae et al., 1995) . Hanover, New Hampshire 03755
One of the CBFA genes, CBFA2 (AML1), is the target 6 Department of Pathology of several chromosomal translocations associated with Brigham and Women's Hospital leukemias and myelodysplasias in humans, including and Harvard Medical School the t(8;21)(q22;q22) associated with de novo acute my-221 Longwood Avenue eloid leukemia (M2 subtype) (Bitter et al., 1987; Miyoshi Boston, Massachusetts 02215 et al., 1991) , the t(12;21)(p13;q22) in de novo acute lymphocytic leukemia (pre-B cell) (Golub et al., 1995; Romana et al., 1995) , and the relatively rare t(3;21) Summary (q26;q22) associated with therapy-related leukemias and myelodysplasias (Nucifora et al., 1993) . All of these The CBF␤ subunit is the non-DNA-binding subunit of translocations result in the production of novel chimeric the heterodimeric core-binding factor (CBF). CBF␤ asproteins containing all or part of the CBF␣2 protein, sociates with DNA-binding CBF␣ subunits and inincluding its DNA-binding domain, fused to a protein creases their affinity for DNA. Genes encoding the encoded on another chromosome.
CBF␤ subunit (CBFB) and one of the CBF␣ subunits
The CBF␤ subunit is encoded by one gene in mam-(CBFA2, otherwise known as AML1) are the most fremals, CBFB, that is ubiquitously expressed (Ogawa et quent targets of chromosomal translocations in acute al., 1993a; Wang et al., 1993) . It is also disrupted in leukemias in humans. We and others previously demleukemias by inv(16)(p13;q22), t(16;16), and del(16)(q22) onstrated that homozygous disruption of the mouse (Liu et al., 1993) . The inv(16) and t(16;16) breakpoints Cbfa2 (AML1) gene results in embryonic lethality at occur primarily in the fifth intron of the CBFB gene and midgestation due to hemorrhaging in the central nerin six different introns of the MYH11 gene, the latter of vous system and blocks fetal liver hematopoiesis.
which encodes a smooth muscle myosin heavy chain Here we demonstrate that homozygous mutation of (SMMHC) (Liu et al., 1993; Shurtleff et al., 1995) . The the Cbfb gene results in the same phenotype. Our result is a chimeric protein that contains amino acids results demonstrate that the CBF␤ subunit is required 1-165 of the CBF␤ protein, including the heterodimerizafor CBF␣2 function in vivo.
tion domain for CBF␣, fused to various lengths of the C-terminal ␣-helical rod domain from SMMHC. A small number of patients have breaks in the fourth intron of Introduction the CBFB gene, which fuses amino acids 1-133 of CBF␤ to SMMHC (Shurtleff et al., 1995) . The CBF␤ (1-133) -The process by which multiple blood cell lineages differ-SMMHC protein generated from the breakpoint in intron entiate from a common pluripotential hematopoietic 4 of the CBFB gene is missing four amino acids (aa stem cell is controlled, in part, by transcription factors 134-137) of the heterodimerization domain, which form that regulate the expression of lineage-specific genes part of an ␣ helix extending from aa 129-136 (unpublished data) . CBF␤ lacking these four amino acids weakly associates with CBF␣ on DNA in vitro, while sequences (aa 94) completely disrupts heterodimeriza-CBF␣ subunit in vitro, a partially functional CBF␤ protein should be synthesized as a result of this mutation. Using tion with CBF␣ (unpublished data).
CBF binding sites are found in putative target genes the targeting vector shown in Figure 1B , we isolated seven correctly targeted ES cell clones from 190 G418/ transcribed in hematopoietic cells, including genes encoding cytokines (GM-CSF, IL-3), cell surface differenti-FIAU-resistant clones ( Figure 1C ), corresponding to a targeting frequency that was 10-fold higher than that ation markers (TCR CD3⑀, CSF-1 receptor), and enzymes (myeloperoxidase, neutrophil elastase, granzyme B serwhich we obtained for the exons 4-5 deletion. Two Cbfb ϩ/Ϫ ES cell clones that were injected into blastocysts ine protease) (for review, see Speck and Stacy, 1995) . The association of the CBFA2 gene with leukemias and yielded high percentage chimeric mice that transmitted the ES cell through the germline. Mice heterozygous for the presence of CBF binding sites in genes transcribed in hematopoietic cells suggested that one or more of the mutation were interbred and their progeny analyzed. Analysis of mRNA and protein in Cbfb ϩ/ϩ, ϩ/Ϫ, the CBF genes is required for hematopoiesis. We and others recently showed that homozygous disruption of and Ϫ/Ϫ ES cells and embryos indicated that truncated CBF␤ proteins lacking exon 5-encoded sequences were the mouse Cbfa2 gene blocks fetal liver but not yolk sac hematopoiesis (Okuda et al., 1996; Wang et al., 1996) . synthesized at low levels from the hypomorphic Cbfb allele (Figure 2) . A 633 bp product was amplified by Embryos homozygous for the Cbfa2 mutation died in midgestation with extensive hemorrhages in the central reverse transcriptase polymerase chain reaction (RT-PCR) from Cbfb ϩ/ϩ embryos, and a smaller 506 bp prodnervous system (CNS), at nerve/CNS interfaces of cranial and spinal nerves, and in somitic/intersomitic reuct was amplified from Cbfb Ϫ/Ϫ embryos, using primers derived from exons 1 and 6 (Figure 2A ). RT-PCR prodgions along the presumptive spinal cord (Okuda et al., 1996; Wang et al., 1996) . Hemorrhaging was preceded ucts amplified from Cbfb Ϫ/Ϫ embryos were subcloned and sequenced ( Figure 2B ). Most of the subcloned inby perivascular edema and apoptosis in these areas and appears to have been caused by damage to developing serts were 506 bp and contained sequences derived from exons 1, 2, 3, 4, and 6; the remaining inserts concapillaries unpublished data) .
The association of inv(16)(p13;q22) and t(16;16) with tained sequences from exons 1, 2, 3, and 6. It appeared from RT-PCR from Cbfb ϩ/Ϫ embryos that lower amounts acute myeloid leukemias suggested that altered forms of the CBF␤ subunit could interfere with CBF function, of mRNA were produced from the hypomorphic Cbfb allele (Figure 2A ), and this was confirmed by whole but it did not indicate whether or not the normal CBF␤ subunit is essential for CBF function in vivo. Here we mount in situ hybridization ( Figure 2C ). Cbfb expression is seen in the telencephalon, cranial ganglia, and the show that the Cbfb gene is essential for embryogenesis. Embryos homozygous for a Cbfb mutation die in middorsal root ganglia in 11.5 days postcoitum (dpc) embryos. The fetal liver displayed a fine, streaky pattern of gestation with extensive hemorrhages in the CNS and petechial hemorrhages at nerve-CNS interfaces of crastaining, suggesting a low level of expression in this tissue. A noticeable decrease in Cbfb mRNA expression nial and spinal nerves and in somitic/intersomitic regions along the presumptive spinal cord, and they was observed in Cbfb Ϫ/Ϫ compared to ϩ/ϩ embryos, although the pattern of expression was identical. exhibit a severe impairment in fetal liver hematopoiesis-the same spectrum of abnormalities found in emAn approximately 21-22 kDa protein was detected by Western blot in extracts prepared from Cbfb ϩ/ϩ and bryos homozygous for disruption of the Cbfa2 gene, indicating that CBF␤ is required for CBF␣2 function ϩ/Ϫ ES cells and 11.5 dpc embryos ( Figure 2D ), consistent with the molecular weight of the CBF␤ (182) Figure 1A ) (Ogawa et al., 1993a; Golling Quantitative Western blotting (see Experimental Proceet al., 1996) . Our initial attempt to disrupt the Cbfb gene dures) indicated that the concentration of wild-type with a targeting construct that replaced both exons 4 CBF␤ protein in ϩ/ϩ ES cells is approximately 4 ϫ 10
Ϫ7
and 5 with the neo r gene yielded only one correctly M and that the truncated CBF␤ proteins in Cbfb ϩ/Ϫ ES targeted ES cell clone, which upon injection into blastocells are 5-to 10-fold less abundant than CBF␤ procysts yielded no live pups. Since the Cbfb gene is exduced from the wild-type allele (data not shown). pressed in ES cells, we reasoned that a 50% reduction A protein:DNA complex specific for the core site was of the CBF␤ concentration might be incompatible with observed by electrophoretic mobility shift assay (EMSA) cell growth. We therefore decided to create a hypomorin extracts prepared from Cbfb ϩ/ϩ and Cbfb ϩ/Ϫ embryos phic Cbfb allele, replacing only the 5Ј half of exon 5 but not from Cbfb Ϫ/Ϫ embryos ( Figure 2E , lanes 1-9). with the neo r gene. This mutation should result in the CBF␤ activity was also assayed by adding exogenous synthesis of a CBF␤ protein lacking the last four amino CBF␣2 to embryo extracts and determining whether the acids (aa 134-137) of the heterodimerization domain.
extracts contained an activity that would shift the Since a CBF␤ protein truncated to the C-terminus of CBF␣2:DNA complex to a more slowly migrating form indicative of association with the CBF␤ subunit. Extracts exon 4-encoded sequences weakly associates with the prepared from Cbfb ϩ/ϩ embryos contained CBF␤ activmately 2.7 ϫ 10 3 , thus the Kd of CBF␤(155) for the CBF␣2:DNA complex is approximately 1.8 ϫ 10 Ϫ4 M. ity, whereas extracts prepared from Cbfb Ϫ/Ϫ embryos lacked detectable CBF␤ activity ( Figure 2E , lanes 10-17).
The truncated CBF␤(155) protein produced in Cbfb
Mutation of the Cbfb Gene Results in Embryonic
Lethality and CNS Hemorrhaging ES cells and embryos should associate weakly with the CBF␣ subunit (Shurtleff et al., 1995) . We compared the No live pups homozygous for the hypomorphic Cbfb allele were obtained from a Cbfb ϩ/Ϫ intercross ( Table 1) . affinity of CBF␤(155) for the CBF␣2:DNA complex in vitro to that of an N-terminal fragment of the CBF␤ proWe sacrificed pregnant females at various days postcoitus to establish the time and cause of death. Cbfb
tein that contains an intact heterodimerization domain [CBF␤ ]. A titration of increasing amounts of embryos died between 11.5 and 14.5 dpc and exhibited extensive hemorrhages ( Figure 3 ). Hemorrhaging oc-CBF␤ in binding reactions that contain a fixed amount of the CBF␣2:DNA complex results in a gradual curred primarily in the CNS, as well as in the vicinity of the VII/VIII cranial nerve complex and in intersegmental shift in the migration of the CBF␣2:DNA complex to the more slowly migrating ␣:␤:DNA complex ( Figure 2F , regions along the presumptive spinal cord ( Figure 3A ). Microscopic analysis of 10.5 dpc Cbfb Ϫ/Ϫ embryos relanes 1-16). The concentration of CBF␤(1-141) at which 50% of the CBF␣2:DNA complex is in the ␣:␤:DNA form vealed evidence of perivascular edema and foci of apoptotic or necrotic cells in hemorrhagic areas in the CNS is 6.7 ϫ 10 Ϫ8 M and is equal to the Kd of CBF␤(1-141) for the CBF␣2:DNA complex under these experimental and in cephalic mesodermal tissue ( Figures 3B-3D ). In all cases, apoptosis and perivascular edema appeared conditions ( Figure 2G ). In comparison, only a small amount of the ␣:␤:DNA complex was obtained at the to be associated with actively growing and/or anastomosing capillaries (Figures 3B-3D ; unpublished data). highest concentrations of CBF␤(155) ( Figure 2F , lanes 18-33). The concentrations of CBF␤ (1-141) and CBF␤ (155) Apoptosis and perivascular edema were also observed in 10.5 dpc Cbfb Ϫ/Ϫ animals in which hemorrhaging was required to form equivalent amounts of the ␣:␤:DNA complex (lanes 4-5 and 33) differ by a factor of approxinot yet apparent. Therefore, mutation of the Cbfb gene (155) proteins were expressed in bacteria as fusion proteins and contain three extra amino acids at their N-termini remaining from the protease cleavage site and the uncleaved initiating methionine. These three additional amino acids may contribute to the slightly slower migration of the bacterially produced proteins relative to the endogenous proteins. Lanes 1-3 contain lysates from ES cells, and lanes 6-8 contain lysates from 11.5 dpc embryos. (E) Electrophoretic mobility shift assays. Lanes 1-9, core-binding activity in 12.5 dpc Cbfb ϩ/ϩ, ϩ/Ϫ, or Ϫ/Ϫ embryos. Lanes 1, 4, and 7 are binding in the absence of competitor DNA; lanes 2, 5, and 8 are binding in the presence of excess unlabeled double-stranded DNA containing an intact CBF binding site; lanes 3, 6, and 9 are binding in the presence of an excess competitor DNA containing a mutated CBF binding site. Large arrow indicates the specific protein:DNA complex, small arrow indicates a nonspecific protein:DNA complex found in all extracts. (C) Mesencephalic region, near the VII cranial nerve in a 10.5 dpc Cbfb Ϫ/Ϫ embryo showing perivascular edema (arrowheads), lineal hemorrhages (rectangles) extending down to the ventricular (V) surface, and intraventricular hemorrhage (V). Notice that both the perivascular edema and the hemorrhages are located roughly at the level of the short-linked anastomotic capillary plexus of the developing CNS. Crossing the marginal zone vertically, two undamaged leptomeningeal perforating capillaries (arrows) are visible on the left side of the figure. The pial (P) surface is also illustrated. (D) Section at the level of the isthmus of a 10.5 dpc Cbfb Ϫ/Ϫ embryo showing a linear zone of cellular apoptosis (arrowheads) and a capillary (asterisk) with perivascular edema. No hemorrhaging was observed in this particular animal; thus, both direct endothelial cell damage and perivascular edema are believed to precede the hemorrhages. The ventricular (V) and pial (P) surfaces are also illustrated. appears to cause apoptosis or necrosis at multiple spehemorrhaging, and mortality in Cbfb Ϫ/Ϫ embryos was essentially identical to that seen in Cbfa2-deficient emcific sites in the embryo that precedes hemorrhaging in these areas. The timing and location of apoptosis, bryos . embryos. The inset in the ϩ/ϩ liver contains a megakaryocyte. In contrast, primarily nucleated yolk sac-derived erythrocytes are visible in the sinusoids of a Cbfb Ϫ/Ϫ littermate, and very few hematopoietic precursors. Sections were stained with hematoxylin and eosin. (C) Liver cytocentrifuge preparations from 12.5 dpc Cbfb ϩ/ϩ and Ϫ/Ϫ embryos. Equal volumes of a mechanically disrupted liver cell suspension were centrifuged onto slides and stained with Wright-Giemsa.
Fetal Liver Hematopoiesis Is Severely right panel)
. Approximately equal numbers of nucleated yolk sac-derived erythrocytes were found in fetal livers Impaired in Cbfb Ϫ/Ϫ Embryos Homozygous disruption of the Cbfa2 gene caused a from both Cbfb ϩ/ϩ and Ϫ/Ϫ embryos (not shown), whereas the number of more blast-like progenitors of block in fetal liver hematopoiesis, whereas primitive yolk sac hematopoiesis was spared (Okuda et al., 1996;  definitive erythroid and myeloid cells was approximately 100-fold lower in livers from Cbfb Ϫ/Ϫ embryos than Wang et al., 1996) . Yolk sac hematopoiesis was largely intact in Cbfb Ϫ/Ϫ embryos, judged by microscopic analyfrom ϩ/ϩ embryos ( Figure 4C ). In addition, definitive erythroblasts were rarely seen in peripheral blood from sis of the yolk sac (not shown) and by similar numbers of circulating yolk sac-derived nucleated erythrocytes 12.5 dpc Cbfb Ϫ/Ϫ embryos but were commonly found in peripheral blood from ϩ/ϩ littermates ( Figure 4A ). in Cbfb ϩ/ϩ and Ϫ/Ϫ embryos ( Figure 4A ). In contrast, fetal liver hematopoiesis in Cbfb Ϫ/Ϫ embryos was seHematopoiesis in Cbfb Ϫ/Ϫ embryos was also examined in in vitro methylcellulose colony forming assays (Wong verely impaired (Figures 4B and 4C) . Liver sections from 12.5 dpc ϩ/ϩ embryos contained an abundance of heet al., 1986) ( Table 2 ). Definitive erythroid, myeloid, and mixed erythroid/myeloid colonies differentiated from matopoietic cells ( Figure 4B , left panel), including an occasional megakaryocyte ( Figure 4B, inset) . In conCbfb ϩ/ϩ and ϩ/Ϫ yolk sac cells, but essentially no colonies differentiated from Cbfb Ϫ/Ϫ cells. In fetal liver trast, fetal livers from 12.5 dpc Cbfb Ϫ/Ϫ embryos contained primarily yolk sac-derived nucleated erythrocolony assays, there was no difference in the number of erythroid, myeloid, and mixed erythroid/myeloid procytes in the liver sinusoids and blood vessels and very few definitive erythroid or myeloid elements ( Figure 4B , genitors in Cbfb ϩ/ϩ and ϩ/Ϫ embryos, whereas were scored on day 7 of incubation. E, erythroid colonies; M, myeloid colonies; Mix, erythroid-myeloid mixed colonies. Average number of colonies per yolk sac is indicated, followed by standard deviation in parentheses. The difference between the numbers of colonies from Cbfa2 ϩ/Ϫ and ϩ/ϩ fetal livers is significant at P Ͻ 0.02 by Student's t test. There is no significant difference between the number of colonies from Cbfb ϩ/ϩ and ϩ/Ϫ yolk sacs and fetal livers. The relatively large standard deviation can be attributed primarily to variation between litters. b Data for Cbfa2 E10.5 yolk sac progenitors is published elsewhere .
Cbfb Ϫ/Ϫ fetal livers contained approximately 30-to 500-small numbers of colonies (Tables 2 and 3 ). This result, together with the observation that embryos heterozyfold fewer erythroid and myeloid progenitors. These results further substantiate the conclusion that fetal liver gous for the Cbfb mutation appear to have wild-type levels of hematopoietic progenitor cells (Table 2) , sughematopoiesis is severely impaired in Cbfb Ϫ/Ϫ embryos. However, the in vitro progenitor assays suggest that the gests that the level of CBF␣2 is limiting in hematopoietic progenitor cells but the level of CBF␤ is saturating. block in fetal liver hematopoiesis is less severe in Cbfb Ϫ/Ϫ embryos, where some colonies are consistently observed, than in Cbfa2 Ϫ/Ϫ embryos, for which essentially Cbfb Ϫ/Ϫ ES Cells Do Not Contribute to Hematopoietic Cells In Vivo no erythroid or myeloid colonies differentiate in vitro (Table 2) (Okuda et al., 1996) .
The Cbfa2 gene is required for lymphopoiesis, as demonstrated by the failure of Cbfa2 Ϫ/Ϫ ES cells to contribute to hematopoietic tissues in chimeric animals (Okuda Mild Dosage Effects Suggest That CBF␣2 (AML1), but Not CBF␤, Is Limiting et al., 1996) and to rescue the defect in T and B cell differentiation in RAG-2-deficient chimeric mice (unpubin Hematopoietic Cells We previously reported that yolk sacs from embryos lished data). We generated Cbfb Ϫ/Ϫ ES cells and assessed their ability to contribute to hematopoietic tisheterozygous for mutation of the Cbfa2 gene consistently contained fewer progenitors for erythroid and mysues in chimeric animals. Cbfb ϩ/Ϫ ES cell clones gave rise to high percentage (>90%) chimeras, whereas eloid colonies than yolk sacs from wild-type embryos and concluded that there appeared to be a mild dosage Cbfb Ϫ/Ϫ ES cells generated chimeras that contained between 30% and 70% agouti coat color. We analyzed effect associated with mutation of the Cbfa2 gene . We confirmed this result in fetal liver prothe contribution of the ES cells to different tissues by glucose phosphate isomerase (GPI) isoform analysis genitor assays (Table 2 ). This mild dosage effect was not seen with the Cbfb mutation, where we saw no ( Figure 5 ) (Williams et al., 1994) . Cbfb ϩ/Ϫ ES cells contributed to all tissues examined, although consistently less significant difference in the numbers of hematopoietic progenitor cells in yolk sacs or fetal livers from Cbfb well to thymus than to other tissues. Cbfb Ϫ/Ϫ ES cells contributed well to most nonhematopoietic tissues ϩ/ϩ and ϩ/Ϫ embryos (Table 2) .
To further characterize the gene dosage effect, we (heart, kidney, brain, adrenal gland), only weakly to liver, bone marrow, and occasionally spleen and lung, and interbred mice heterozygous for the Cbfa2 and Cbfb mutations toobtain transheterozygous Cbfa2 ϩ/Ϫ :: Cbfb ϩ/Ϫ not at all to peripheral blood or thymus. The data suggest that the block in hematopoiesis is cell autonomous, progeny and interbred these mice to obtain F2 progeny (Table 3) . We observed no accentuation of hemorrhaging since hematopoiesis of Cbfb Ϫ/Ϫ ES cells does not occur in the microenvironment of the hematopoietic compartor mortality in 11.5 dpc Cbfa2 Ϫ/Ϫ ::Cbfb Ϫ/Ϫ embryos compared to Cbfa2 Ϫ/Ϫ ::Cbfb ϩ/ϩ or Cbfa2 ϩ/ϩ :: Cbfb Ϫ/Ϫ emment of a normal mouse. The small contribution to bone marrow and spleen may indicate that the block in hemabryos. Of the five Cbfa2 Ϫ/Ϫ ::Cbfb Ϫ/Ϫ embryos analyzed, three (60%) had visible hemorrhages at 11.5 dpc, comtopoiesis is not as severe as that caused by the Cbfa2 mutation. pared to 73% of Cbfa2 Ϫ/Ϫ embryos and 60% of Cbfb Ϫ/Ϫ embryos (see Table 1 ). et al., 1993b; Wang et al., 1993; unpublished results) . Cbfb mutations, along with biochemical data demonstrating that the CBF␣ and ␤ subunits exist as a complex, Disruption of the Cbfa2 (AML1) gene, which encodes a DNA-binding CBF␣ subunit, results in embryonic lethalstrongly argue that the CBF␤ subunit is essential for CBF␣2 function in vivo. There are two other CBF␣ subity accompanied by perivascular edema, apoptosis or necrosis, hemorrhaging in the CNS, and a block in fetal units in mice, CBF␣1 and CBF␣3, that can heterodimerize with CBF␤ (Ogawa et al., 1993b; Bae et al., 1995) . liver hematopoiesis (Okuda et al., 1996; Wang et al., 1996) . Here we show that homozygous mutation of the Our data indicate that CBF␣2 is the first CBF␣ subunit expressed during development that requires heterodimCbfb gene results in the same spectrum of abnormalities seen in Cbfa2-deficient mice. Mutations in other genes erization with the CBF␤ subunit for in vivo function. Since a smaller CBF␤ protein is produced from the muencoding transcription factors that severely disrupt either yolk sac and/or definitive hematopoiesis, including tated allele that may participate in other cellular processes, we cannot conclude from our data that the only Scl/TAL-1, Rbtn2, Gata1, Gata2, Gata3,  or PU.1, do not cause the same pathological changes associated role of CBF␤ in the cell involves association with CBF␣ subunits. However, disruption of exon 1 of the Cbfb with CNS hemorrhaging seen in Cbfa2-and Cbfb-deficient mice (Mucenski et al., 1991; Pevny et al., 1991;  gene, which presumably does result in a null allele, also caused midgestation lethality, CNS hemorrhaging, and Scott et al., 1994; Tsai et al., 1994; Warren et al., 1994; Pandolfi et al., 1995; Shivdasani et al., 1995) . The strikimpairment of fetal liver hematopoiesis (Y. Ito et al., personal communication), providing more substantial ingly similar phenotypes resulting from the Cbfa2 and evidence that this is indeed its only cellular function. The essentially identical phenotypes of Cbfa2-and Cbfb-deficient mice are reminiscent of the similar phenotypes associated with disruptions of the Rbtn2 and Scl/TAL-1 genes, which also encode structurally unrelated proteins that form a complex in erythroid cells in vivo (Valge-Archer et al., 1994) . Both proteins are required for erythropoiesis, as homozygous disruption of either the Rbtn2 or Scl/TAL-1 gene results in embryonic lethality and a block in yolk sac erythropoiesis Shivdasani et al., 1995) .
The CBF␤ subunit increases the affinity of the CBF␣ subunit for DNA by ‫-5ف‬ to 10-fold (Ogawa et al., 1993a; Wang et al., 1993) . We reported previously , and confirm in these studies, that a mild dosage effect is associated with mutations in the Cbfa2 gene, indicating that the concentration of CBF␣2 may be limiting in hematopoietic progenitor cells. If CBF␣2 is limiting, the absence of CBF␤ in Cbfb Ϫ/Ϫ embryos might increase the K d of the CBF␣2 subunit for DNA to the of the CBF␤ subunit in the CBF complex may be to
The different panels represent chimeric mice generated from indedecrease the Kd of CBF␣2 for its site, and it is conceivpendent ES cell clones. Lanes: 129/Sv, J1 ES cells; H, heart; PB, able that it has no other biochemical role in the transcripperipheral blood; BM, bone marrow; L, liver; S, spleen; K, kidney; Lu, lung; T, thymus; B, brain; A, adrenal. tion process. Shurtleff et al. (1995) identified three cases of CNS tissue itself undergo considerable cellular growth and migration at this stage of embryogenesis (Andres, inv(16)(p13q22) and t(16;16)(p13;q22) in which breakpoints occurred in the fourth intron of the CBFB gene, 1967; Krisch et al., 1984; Marín-Padilla, 1985) , which may render them particularly susceptible to damage. In generating CBF␤ (1-133) -SMMHC fusion proteins that lack aa 134-137 from the CBF␤ heterodimerization domain.
this and other studies, we show that perivascular edema and apoptosis appear to be associated with actively Presumably, these CBF␤ (1-133) -SMMHC fusion proteins interfere with wild-type CBF function and contribute to growing and/or anastomosing capillaries, but that vasculogenesis in general is not impaired ; leukemogenesis in these patients. We anticipated that the mutation we introduced would create a relatively unpublished data). Although we do not understand the underlying cause of the damage to growing capillaries weak allele of the Cbfb gene, and our finding that the mutation in its homozygous state resulted in embryonic in Cbfa2-and Cbfb-deficient embryos, we offer three possible explanations. One hypothesis is that CBF is lethality was unexpected. It is somewhat difficult to explain how the CBF␤(1-133)-SMMHC fusion protein can directly involved in certain aspects of vasculogenesis, particularly within the CNS. In this regard, it will be imtransdominantly interfere with wild-type CBF function sufficiently well to block hematopoiesis, when a CBF␤ portant to determine if Cbfa2 and Cbfb are expressed in endothelial cells. A second hypothesis is that loss of protein lacking these same amino acids from the heterodimerization domain is inadequate for wild-type CBF CBF function in the CNS and in sensory and motor ganglia may perturb the microenvironment that supports function. One explanation is that the CBF␤ (1-133) -SMMHC fusion protein might be expressed at higher levels in the growth or integrity of actively growing capillaries. A third possible explanation is that the embryos may suffer leukemic cells than wild-type CBF␤ protein synthesized from the remaining normal allele. If this is not the case, from mild hypoxia, which preferentially affects capillaries with the highest levels of cellular activity in the emthen the CBF␤ (1-133) -SMMHC protein must be a highly potent transdominant inhibitor of CBF function.
bryo at this time of development. This last hypothesis would imply that mutation of the Cbfa2 and Cbfb genes Our original attempts to delete both exons 4 and 5 of the Cbfb gene were unsuccessful for reasons that realso affects primitive erythropoiesis to some extent, since yolk sac-derived primitive erythroid cells are esmain unclear. Although we originally hypothesized that a 50% reduction of the CBF␤ concentration was detrisentially the only hematopoietic cells in peripheral blood at 10.5 dpc. In the accompanying paper, Castilla et al. poiesis. This suggests that Cbfb also plays a role in yolk sac hematopoiesis and that perhaps a subtle defect However, a truncated CBF␤ protein was undetectable in extracts prepared from the ES cell line heterozygous in primitive erythropoiesis is present in Cbfb-deficient embryos that was not detected histologically. Although for the exons 4-5 disruption by Western blot (data not shown). Thus, if a truncated protein is expressed, it mutations in other genes that profoundly affect yolk sac hematopoiesis, such as Gata2, Scl1, and Rbtn2, are not accumulates to relatively low levels. Although it remains formally possible that low levels of a truncated protein associated with CNS hemorrhaging (Tsai et al., 1994; Warren et al., 1994; Shivdasani et al., 1995) , most emcould interfere with wild-type CBF␤ function in ES cells, this is incompatible with the observation that homozybryos homozygous for these mutations die before 11.5 dpc, when CNS hemorrhaging is prevalent in Cbfa2-and gous mutation of the Cbfb gene resulted in midgestation embryonic lethality, suggesting no essential role for Cbfb-deficient embryos. Cbfb in early embryogenesis.
Experimental Procedures
Hemorrhaging occurs at specific sites in 11.5-12.5 dpc Cbfb Ϫ/Ϫ and Cbfa2 Ϫ/Ϫ embryos-at nerve/CNS inter- 
1970
) and expression of prothrombin (Soifer et al., 1994) .
syl]-5 isodouracil (Eli Lilly) (FIAU) resistant ES cell colonies were Therefore, bleeding cannot be caused by the absence picked and expanded as described (Li et al., 1992) . Genomic DNA was prepared and analyzed by Southern blot. Two independent of circulating platelets, which would also not be present ing the VII/VIII cranial nerve complex and dorsal root were mated. Genotypes were determined by Southern blot analysis ganglia (Simeone et al., 1995; this manuscript) , areas of tail, embryo, or yolk sac DNA ( Figure 1D ). No phenotypic differwhere apoptosis and hemorrhaging consistently occur.
ences were observed in progeny mice derived either from independently targeted ES cell clones or on different genetic backgrounds.
The capillaries in these nerve-CNS interfaces and in the Cbfb Ϫ/Ϫ ES cells were selected from Cbfb ϩ/Ϫ JI cells by growth in Electrophoretic Mobility Shift Assays Extracts from 11.5 dpc embryos were prepared by sonication in 0.4 4.0 mg/ml G418 (Mortensen et al., 1992) . ml of 29 mM HEPES (pH 7.8), 450 mM NaCl, 0.2 mM EDTA, 1 mM dithiothreitol, 25% glycerol, plus protease inhibitors. Assays were Histological Analysis performed as previously described using a high affinity (HA) DNA Histology was performed as described previously (Wang et al., site and unlabeled HA and mutant (MUT) core sites as competitors 1996). Peripheral blood cells were collected from 12.5 dpc embryos (Thornell et al., 1991; Wang and Speck, 1992) . The DNA-binding by severing the placenta, quickly rinsing the embryo and yolk sac domain of the CBF␣2 subunit used in binding reactions was derived in Alpha minimum essential medium (GIBCO-BRL), 2% fetal calf from amino acids 51-190 of the murine CBF␣2 protein (Bae et al., serum, and 0.75% bovine serum albumin, then placing the embryo 1993) and contains a five-amino acid C-terminal tag (KNQHE) (Bowie and yolk sac in 1 ml of the same medium for several minutes. The and Sauer, 1989) . Expression and purification of this domain from released blood cells were collected and 4 ϫ 10 4 cells centrifuged bacteria will be described elsewhere. onto slides and stained with Wright-Giemsa. Fetal livers from 12.5 dpc embryos were disrupted with a 25-gauge needle in 1 ml of the Determination of Dissociation Constants same medium, and approximately 7 l was diluted into 200 l of The CBF␣2(51-190) protein contained a hexahistidine tag followed by medium, cytocentrifuged, and stained with Wright-Giemsa.
two FLAG epitopes incorporated at its N-terminus and was expressed in SF9 insect cells from a recombinant baculovirus and In Situ Hybridization purified from a nuclear extract by sequential chromatography on Staged mouse embryos were dissected and fixed in 4% paraformalNi-NTA agarose followed by an anti-FLAG M2 monoclonal antibody dehyde in phosphate-buffered saline plus 0.1% Tween 20 (PBT). A column (Eastman Kodak). Expression and purification of this tagged pBluescript SKϩ (Stratagene)-based plasmid containing nucleo-CBF␣2 protein from insect cells will be described in more detail tides 82-703 from the CBF␤ p21.5 cDNA (Wang et al., 1993) was elsewhere. The concentration of active CBF␣2 protein was deused to generate strand-specific RNA probes labeled with digoxitermined in DNA titration experiments (Jonsen et al., 1996) . The genin UTP. Whole mount in situ hybridization was performed as CBF␤ proteins analyzed include an N-terminal 141 aa fragment from described (Wilkinson, 1992; Rosen and Beddington, 1993) . the CBF␤ p21.5 protein and CBF␤(155). The concentration of CBF␤ proteins was determined by absorbance at 280 nm using an extinction coefficient (⑀) of 18,500 M
Ϫ1
•cm Ϫ1 (unpublished data). Binding Cbfb cDNA Analysis conditions were chosen such that the concentration of DNA was Total RNA from 11.5 dpc embryos was analyzed by RT-PCR as >10-fold above the K d of CBF␣2 for the DNA site (7.5 ϫ 10 Ϫ9 M described previously , using primers from exon DNA), and the concentration of active CBF␣2 , along with 6 (5Ј-GAGATGGGGCACATAAG-3Ј). The PCR products were sepavarious amounts of CBF␤ proteins, was used in binding reactions, rated by agarose gel electrophoresis, transferred to a nylon memand the complexes were resolved by EMSA. Binding reactions (20 brane, and the blot hybridized with a 32 P-labeled oligonucleotide l total volume) were performed on ice for 20 min in 10 mM Tris-HCl derived from exon 4 (5Ј-TGGAAGGGCTGGATTGATC-3Ј).
(pH 7.5), 100 mM NaCl, 1 mM EDTA, 5 mM DTT, 0.2 g•ml Ϫ1 bovine For subcloning purposes, RT-PCR was done using the same serum albumin (BSA), 0.05% Triton X-100, and 4% glycerol. Binding exon 1 primer and a primer from exon 6 (5Ј-GTTAAGCAACCCTGA reactions (15 l) were loaded onto a running gel (10% polyacryl-TAC-3Ј) 3Ј to a PstI site. Amplified products were digested with amide) at 4ЊC. Results were obtained on a Molecular Dynamics BamHI and PstI and subcloned into the corresponding sites of Phosphoimager 445SI scanner (Molecular Dynamics, Sunnyvale, pBluescript SKϩ. Insert sequences from several independent colo-CA) and quantified using IPLab gel. The data is plotted as the percent nies were determined using the PRISM TM Sequencing Kit (Perkin CBF␣2 :CBF␤:DNA complex versus the concentration of CBF␤, Elmer Cetus) and analyzed on an Applied Biosystems Automated and the K d is defined as the concentration of CBF␤ at 50% saturation Sequencer Stretched 373A (Perkin Elmer Cetus). The PCR products (Kaleidagraph: Synergy Software). One hundred percent ternary were also subcloned into a vector for expression in bacteria. The complex was defined as the point of saturation, and 0% ternary bacterial expression vector and purification protocol for CBF␤ and complex is taken from the background at that position in the abits truncated derivatives will be described elsewhere.
sence of added CBF␤.
Western Blot Analyses
Methylcellulose Colony Forming Assays Cbfb ϩ/ϩ, ϩ/Ϫ and Ϫ/Ϫ ES cells were cultured without feeder cells, Cultures of yolk sac cells were performed as described previously and lysates were collected in IP buffer (150 mM NaCl, 50 mM Tris . Livers were dissected from 11.5 dpc embryos [pH 8.0], 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 0.2 mM in cold PBS and transferred to 50 ml tubes containing 5 ml Alpha EDTA, 2.0 mM EGTA) plus protease inhibitors (1 g/ml pepstatin A, 1 minimum essential medium with 5% FCS and 0.75% BSA. A single M Pefablock, 2 g/ml leupeptin, 2 g/ml aprotinin). Whole embryos cell suspension was achieved by passing the liver through a 21-were placed in 400 l cold homogenization buffer (25 mM HEPES gauge needle twice and a 25-gauge needle once. Cells were washed [pH 7.4], 100 mM NaCl), plus the same protease inhibitors described once more and resuspended in 0.3 ml medium. One tenth of the for IP buffer, and subjected to two 15 s pulses with an Ultraturrax cells were plated in one 35 mm plate and the remainder of the cells tissue homogenizer. Lysates were boiled in SDS loading buffer and were cultured in another 35 mm plate. Cells were grown in the same resolved by SDS-PAGE on 13% gels, and the proteins were transmedium and conditions described for yolk sac cultures. ferred to nitrocellulose. CBF␤ proteins were detected with a mouse monoclonal antibody (␤141.2) and ECL reagents (Amersham). Hybridoma clone ␤141.2 was produced after immunization with bacte-GPI Analysis Separation and detection of GPI isoenzymes was performed as rially expressed CBF␤(1-141) following standard procedures (Harlow and Lane, 1988) .
described by Williams et al. (1994) . Tissue samples were homogenized in 1:1 weight/volume ratio of sterile H 2O and subjected to Quantitative Western blots were performed by diluting known amounts of CBF␤ into lysates from 1 ϫ 10 4 J1 ES cells, followed three freeze/thaw cycles. Most homogenates were further diluted between approximately 1:50 and 1:100 into H 2 O, except peripheral by SDS-PAGE and Western blotting with ␤141.2 antibody. The proteins were quantified by densitometry and analyzed using the scienblood, which was diluted 1:5. Samples were applied to Titan III Zip Zone cellulose acetate plates presoaked in Tris-glycine buffer ( turer's instructions (Helena Laboratories, Beaumont, TX).
